Pathstone Holdings LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 153,486 shares of the healthcare conglomerate’s stock after purchasing an additional 1,388 shares during the quarter. Pathstone Holdings LLC’s holdings in UnitedHealth Group were worth $89,731,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently made changes to their positions in UNH. International Assets Investment Management LLC lifted its position in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Swedbank AB bought a new stake in shares of UnitedHealth Group during the 1st quarter worth $1,117,462,000. Lone Pine Capital LLC bought a new position in UnitedHealth Group in the second quarter valued at $480,903,000. Dimensional Fund Advisors LP lifted its stake in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. Finally, Baillie Gifford & Co. raised its holdings in shares of UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after buying an additional 821,050 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
UNH has been the topic of a number of recent research reports. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. TD Cowen lifted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Royal Bank of Canada decreased their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $615.53.
UnitedHealth Group Stock Down 0.4 %
NYSE:UNH opened at $589.65 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm’s 50-day moving average price is $582.75 and its 200-day moving average price is $550.66. The company has a market capitalization of $542.64 billion, a PE ratio of 38.41, a P/E/G ratio of 1.74 and a beta of 0.58.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.56 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- How Can Investors Benefit From After-Hours Trading
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What Are Trending Stocks? Trending Stocks Explained
- Applied Materials Market Capitulates: Now is the Time to Buy
- Market Cap Calculator: How to Calculate Market Cap
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.